BALYASNY ASSET MANAGEMENT L.P. - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$13,00015,4290.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders